Piermont Capital Management Inc. - PROGENICS PHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 107 filers reported holding PROGENICS PHARMACEUTICALS IN in Q2 2016. The put-call ratio across all filers is 20.80 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
Piermont Capital Management Inc. ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2016$1,549,000
-30.5%
355,389
-2.2%
0.49%
-30.3%
Q4 2015$2,229,000
+7.2%
363,5490.0%0.71%
+4.4%
Q3 2015$2,080,000
-20.5%
363,549
+3.7%
0.68%
-13.9%
Q2 2015$2,616,000–350,694–0.79%–
 Download
Other shareholders

There were no reported owners of PROGENICS PHARMACEUTICALS IN in Q2 2016.

NameSharesValueWeighting ↓
View complete list of PROGENICS PHARMACEUTICALS IN shareholders